Prof. Soper gives presentation at TRI-CON Conference

Center Director, Professor Steve Soper will give a presentation at the TRI-CON Conference at the Moscone Center in San Francisco, CA, on interrogating DNA damage in CTCs to monitor response to therapy. The technology uses nanofluidic devices emanating from CBM² to stretch DNA and optically read the chemotherapy-induced DNA damage sites.

March 22, 2017